Search

Search Constraints

You searched for: Author/Creator Fabbro, Michel

Search Results

1. 2022-RA-1088-ESGO Chitinase response after 3 cycles of chemotherapy as a promising marker of chemosensitivity an ancillary analysis of the GINECO-ENGOT EWOC-1 trial. (20th October 2022)

2. 2022-RA-823-ESGO FOXL2 mutation detection in circulating tumor DNA of adult granulosa cell tumors as a potential biomarker for disease monitoring from the randomized ALIENOR trial, a GINECO study. (20th October 2022)

3. 2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study. (20th October 2022)

4. 364 Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/ENGOT-OV26/GOG-3012 study. (4th December 2020)

5. A Double‐Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl‐L‐Carnitine in the Prevention of Sagopilone‐Induced Peripheral Neuropathy. (8th October 2013)

6. A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study. Issue 8 (17th May 2019)

7. Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile: A Phase 2 Trial. Issue 9 (1st November 2012)

9. Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study. (11th June 2019)

10. Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA. (16th January 2014)